The present post-transcriptional regulation tool, which targets endogenous mRNA translation, increased the expression of the targeted proteins (PTEN and P53) while suppressing the proliferation and migration of bladder cancer cells. This evidence concerns the gene PTEN and urinary bladder cancer.